Certuity LLC purchased a new stake in Ascendis Pharma A/S (NASDAQ:ASND – Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 2,144 shares of the biotechnology company’s stock, valued at approximately $270,000. Other hedge funds also recently modified their […]